Elif Bacak Güllü
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Elif Bacak Güllü has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Hamza Güllü
Department of Civil Engineering, University of Gaziantep, Gaziantep 27310, Turkey
2 shared publications - Mehmet Emin Yetim
Gaziantep University Department of Civil Engineering, Graduate School of Natural and Applied Sciences Gaziantep
2 shared publications Abdalrhman Kuba
School of Medicine, Gaziantep, Turkiye
1 shared publication- Gülcan Avci
Department of Biochemistry, Faculty of Veterinary Medicine, Afyon Kocatepe University, 03200, Afyonkarahisar, Turkey
1 shared publication - Hülya Çiçek
Gaziantep University
1 shared publication - Mete Gurol Ugur
Department of Obstetrics and Gynecology, Gaziantep University School of Medicine, Gaziantep, Turkey
1 shared publication
Latest Publications
- 11 March 2025
- Published by Taylor & Francis in European Journal of Environmental and Civil Engineering
- Vol. 29 (10) , 1987-2008
Compaction grouting: rheological and fresh-state performances of nano-silica and fly ash
- 11 March 2025
- Published by Taylor & Francis in European Journal of Environmental and Civil Engineering
- Vol. 29 (10) , 1987-2008
Compaction grouting: rheological and fresh-state performances of nano-silica and fly ash
- Open Access
- 15 February 2024
- Published by IP Innovative Publication Pvt Ltd in International Journal of Clinical Biochemistry and Research
- Vol. 10 (4) , 314-319
Assessment of serum markers in preeclampsia: A prospective study
Preeclampsia is a disease characterized by hypertension, proteinuria, and edema that occurs after the 20th gestational week. It is among the most important reasons for maternal/perinatal morbidity and mortality. Although many studies have been carried out, the pathophysiology of the disease is not fully known. Many methods have been proposed for evaluating risk factors leading to preeclampsia. In the past, the methods used to predict preeclampsia have usually been focused on non-biochemical markers, but nowadays there is a shift towards biochemical markers. Recently, many biochemical agents have been started to be used in the prediction of preeclampsia. In this study, the evaluation of some serum biomarkers in the follow-up preeclampsia was aimed. Serum nesfatin, ezrin, placental protein 13, hypoxia-inducible factor 1-α subunit (HIF1A), and neuropilin 1 levels were examined with the ELISA method. In the study, 90 samples taken from subjects, including pre-treatment preeclampsia (n =35), post-treatment preeclampsia (n = 35), and healthy control (n = 20) groups were evaluated. The data obtained from the study was analyzed with SPSS 22.0. As a result of the statistical analysis, pre-treatment nesfatin-1, and ezrin levels were found significantly lower than post-treatment and the healthy control group and HIF-1A levels were found significantly higher. As a result of these analyses, pre-treatment and post-treatment PP13 levels were found to be significantly higher than the healthy control group.Considering the results obtained from the study, we can say that nestin, ezrin, HIF1A, PP13, and NRP1 are important biomarkers for predicting preeclampsia.
- 15 February 2024
- Published by IP Innovative Publication Pvt Ltd in International Journal of Clinical Biochemistry and Research
- Vol. 10 (4) , 314-319
Open AccessAssessment of serum markers in preeclampsia: A prospective study
Preeclampsia is a disease characterized by hypertension, proteinuria, and edema that occurs after the 20th gestational week. It is among the most important reasons for maternal/perinatal morbidity and mortality. Although many studies have been carried out, the pathophysiology of the disease is not fully known. Many methods have been proposed for evaluating risk factors leading to preeclampsia. In the past, the methods used to predict preeclampsia have usually been focused on non-biochemical markers, but nowadays there is a shift towards biochemical markers. Recently, many biochemical agents have been started to be used in the prediction of preeclampsia. In this study, the evaluation of some serum biomarkers in the follow-up preeclampsia was aimed. Serum nesfatin, ezrin, placental protein 13, hypoxia-inducible factor 1-α subunit (HIF1A), and neuropilin 1 levels were examined with the ELISA method. In the study, 90 samples taken from subjects, including pre-treatment preeclampsia (n =35), post-treatment preeclampsia (n = 35), and healthy control (n = 20) groups were evaluated. The data obtained from the study was analyzed with SPSS 22.0. As a result of the statistical analysis, pre-treatment nesfatin-1, and ezrin levels were found significantly lower than post-treatment and the healthy control group and HIF-1A levels were found significantly higher. As a result of these analyses, pre-treatment and post-treatment PP13 levels were found to be significantly higher than the healthy control group.Considering the results obtained from the study, we can say that nestin, ezrin, HIF1A, PP13, and NRP1 are important biomarkers for predicting preeclampsia.
- 18 August 2023
- Published by Taylor & Francis in European Journal of Environmental and Civil Engineering
- Vol. 28 (5) , 1183-1207
On the rheological, fresh and strength effects of using nano-silica added geopolymer grout for grouting columns
- 18 August 2023
- Published by Taylor & Francis in European Journal of Environmental and Civil Engineering
- Vol. 28 (5) , 1183-1207
On the rheological, fresh and strength effects of using nano-silica added geopolymer grout for grouting columns